China approves Pfizer GLP-1 drug for weight loss
On Mar. 5, 2026, China has approved Pfizer’s GLP-1 treatment Xianweiying for long-term weight management in overweight or…
On Mar. 5, 2026, China has approved Pfizer’s GLP-1 treatment Xianweiying for long-term weight management in overweight or…